A phase II study of XL647 in patients with non-small cell lung cancer (NSCLC) enriched for presence of EGFR mutations Meeting Abstract


Authors: Rizvi, N.; Kris, M.; Miller, V.; Krug, L.; Bekele, S.; Dowlati, A.; Rowland, K.; Tonda, M.; Mitchell, B.; Ruckdeschels, J.; Chaplen, R.; Aggarwal, N.; Gadgeel, S.
Abstract Title: A phase II study of XL647 in patients with non-small cell lung cancer (NSCLC) enriched for presence of EGFR mutations
Meeting Title: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics
Journal Title: Molecular Cancer Therapeutics
Volume: 6
Issue: 12
Meeting Dates: 2007 Oct 22-26
Meeting Location: San Francisco, CA
ISSN: 1535-7163
Publisher: American Association for Cancer Research  
Date Published: 2007-12-01
Start Page: 3473S
Language: English
ACCESSION: WOS:000251969000422
PROVIDER: wos
Notes: --- - Meeting Abstract - Poster Presentation - Part 2 - "Source: Wos"
MSK Authors
  1. Naiyer A Rizvi
    166 Rizvi
  2. Vincent Miller
    270 Miller
  3. Mark Kris
    869 Kris
  4. Sara Bekele
    9 Bekele